Gainers
- Revance Therapeutics RVNC shares moved upwards by 16.5% to $6.0 during Friday's pre-market session. The company's market cap stands at $526.8 million.
- Eterna Therapeutics ERNA shares increased by 15.78% to $1.98. The market value of their outstanding shares is at $10.7 million.
- Connect Biopharma Hldgs CNTB stock rose 14.85% to $1.16. The market value of their outstanding shares is at $63.8 million.
- Celularity CELU shares increased by 12.68% to $0.55. The company's market cap stands at $118.3 million.
- Trxade Health MEDS shares rose 12.35% to $5.0. The company's market cap stands at $6.0 million.
- Windtree Therapeutics WINT shares moved upwards by 12.19% to $0.46. The market value of their outstanding shares is at $3.4 million.
Losers
- GRI Bio GRI shares fell 31.8% to $1.33 during Friday's pre-market session.
- Sharps Technology STSS stock fell 12.2% to $0.36. The market value of their outstanding shares is at $5.4 million.
- Biofrontera BFRI shares fell 11.62% to $1.18. The company's market cap stands at $1.9 million.
- Kiora Pharmaceuticals KPRX shares decreased by 10.6% to $0.76. The market value of their outstanding shares is at $5.8 million.
- Cadrenal Therapeutics CVKD shares declined by 9.22% to $1.28. The market value of their outstanding shares is at $16.6 million.
- Corbus Pharmaceuticals CRBP stock declined by 9.04% to $25.28. The market value of their outstanding shares is at $111.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
CELUCelularity Inc
$2.372.85%
CNTBConnect Biopharma Holdings Ltd
$1.05-%
CRBPCorbus Pharmaceuticals Holdings Inc
$11.930.08%
CVKDCadrenal Therapeutics Inc
$18.496.26%
ERNAEterna Therapeutics Inc
$0.42500.66%
GRIGRI Bio Inc
$0.72971.31%
KPRXKiora Pharmaceuticals Inc
$3.992.06%
RVNCRevance Therapeutics Inc
$3.67-0.27%
STSSSharps Technology Inc
$1.860.54%
WINTWindtree Therapeutics Inc
$0.2159-1.46%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in